Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.7 USD | +1.61% | 0.00% | +18.60% |
May. 31 | Qiagen, Myriad Genetics Team Up to Develop Homologous Recombination Deficiency Test | MT |
May. 31 | Qiagen, Myriad Genetics Partner to Create Easily Distributable Cancer Tumor Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.60% | 2.02B | |
-5.37% | 12.35B | |
-3.75% | 8.17B | |
+7.79% | 5.77B | |
+33.10% | 5.65B | |
-12.12% | 4.1B | |
+14.18% | 2.67B | |
-5.70% | 2.31B | |
-6.70% | 1.81B | |
-3.89% | 1.51B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics, Personalis Collaborate to Market ImmunoID NeXT Platform